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The ability of salicylates to protect articular cartilage from
degradation was first shown by Simmons and Chrisman (1964).
In vitro
,
saline extracts of human articular cartilage were found
to decrease the viscosity of chondromucoprotein, a sign of de
gradation of cartilage matrix. This degradation could be inhibited
when salicylate was present in the incubating system at a con
centration of 30-35 mg % (Simmons and Chrisman 1965). In vivo,
the articular cartilages of rabbits' knees were injured by the
scarification method of Meachim (1963). One group of animals
receiving dietary sodium salicylate for serum concentrations of 15-
35 mg % did not develop many of the degenerative changes seen in
the control group. This work was repeated and confirmed by Porzio
and Tuzi (1968). Eyring (1969), who compressed rabbits' knees by
attaching rubber bands to Kirschner wires placed through the distal
metaphysis of the femur and proximal metaphysis of the tibia, also
found that oral salicylate slowed cartilage destruction in this system.
In a clinical study,Chrisman and Snook (1968) further showed that
salicylate protected articular cartilage from developing the chondror-
malacic changes seen after recurrent lateral dislocation of the patella.
Although Miller and Smith (1966) presented evidence that such
anti -inflammatory effects of salicylate might be due to its ability
to stabilize lysosomes, Ennis et al (1968) showed that acetyl-
salicyla e had no protective effect on the release of lysosomal
hydrolases. Many other investigators had also offered hypotheses
to explain the well-known beneficial effects of salicylates in the
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arthritides, yet the mechanisms of action of these compounds remained
largely unknown .
Recently, Vane (1971) suggested that the effects of salicylates might
be mediated by their ability to inhibit the synthesis and/or release of
prostaglandins. These ubiquitous fatty acids are known to have a variety
of effects on a number of tissues. There are a few studies which claim
that the E group of prostaglandins have anti-inflammatory effects
(Aspinall and Cammarata 1969; Zurier and Quagliata 1971), but these
are apparently secondary to adrenal hyperplasia and steroidogenesis
produced by the administration of high doses of prostaglandin E (Flack
et al 1969). On the other hand, there are a multitude of other studies
which implicate the prostaglandins in the production of edema (Bergstrom
etal 1965; Glenn et al 1972), the induction of leukocyte migration
(Kaley and Weiner 1971), and an Increase in vascular permeability
(Kaley et al 1972; Arora et al 1970), processes known to occur in
inflammation (Willis et al 1972). The evidence is markedly in favor
of the E group of prostaglandins being inflammatory in nature.
Salicylates have been shown to inhibit not only the inflammatory
actions of prostaglandins (Willoughby 1971), but also their biosynthesis
in guinea-pig lung homogenates (Vane 1971), human platelets (Smith
and Willis 1971), dog andrabbit spleen (Ferreira etal 1971; Gryglewski
and Vane 1972), rat skin (Greaves and McDonald-Gibson 1972a),
bovine seminal vesicle microsomes (Tomlinson et al 1972), and a line
of mouse fibrosarcoma cells which regularly produce prostaglandin E^
(Levine et al 1972). In each case, the inhibition took place in the
presence of salicylate concentrations known to occur in human plasma
after oral ingestion of a clinically effective dose. Furthermore, there
is evidence fo suggest that inhibition of prostaglandin synthesis can
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explain the three principal actions of salicylate, i.e. anti-inflammatory
(Crunkhorn and Willis 1971), anti-pyretic (Milton and Wendlandt 1970),
and analgesic (Collier and Schneider 1972).
Given the above, the question arises, is the previously noted pro
tective effect of salicylate on articular cartilage mediated by inhibition
of prostaglandin synthesis and/or release in the joint ? In order to answer
this question, it first had to be determined if prostaglandins in the joint
space could induce cartilage degradation similar to that seen by Simmons
and Chrisman (1965). Then, if such degradation could be demonstrated,
could its production be inhibited by oral administration of therapeutic
amounts of salicylate?
Although a degenrative arthritis in rabbit knees had been produced
by Gardner (I960) with the injection of caragheenin, by Weissman et
al (1969) with the injection of lysates of granulocyte lysosomes, and by
Moskowife et al (1970) with the injection of steroids, the only experiment
in which prostaglandins were injected into the knee joint was one done
on dogs by Rosenthale et al (1972). In the last experiment, the deleterious
effect of prostaglandins on the articular cartilage remained a mystery as
the damaging effects of the prostaglandins were evaluated on the basis
of the amount of incapacitation produced in the animal, not on the basis
of histologic evaluation of the knee articular cartilage. In addition, in the
caragheenin system, the cartilage damage could be prevented by administration
of salicylate (Willis etal 1972) whereas the incapacitation produced in the
a
prostaglandin system could not. The effect of slicylate was not tested in
A
Weissmann's system (Weissmann 1969).
Chloroquine has also been shown to have the ability to prevent cartilage
degradation in vivo under conditions identical to Simmons and Chrisman's
original experiment (Volastro et al 1973). Although chloroquine has in
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common with salicylate anti-inflammatory properties, it is neither an
anti-pyretic nor an analgesic. Furthermore, chloroouine can not inhibit
the biosynthesis of prostaglandin E. in rat skin as can salicylate (Greaves and
McDono.d -Gibson 1972b), nor can it matcn salicylate's ability 'to inhibit
prostaglandin synthetase (Ham et al 1972). In fact, the mechanism of action
of chloroquine in the treatment of arthritis is thought to be its ability to
stabilize lysosomes (Weismmann 1964).
Hence, the purpose of the experiment presented here was to compare
the effects of chloroquine and salicylate on articular cartilage damage
produced by injecting prostaglandin into the rabbit knee joint.
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MATERIALS AND METHODS
Prostaglandin E. was selected for use as it has been shown to
be the most potent of the prostaglandins in the production of in-
flamma.ion (Juhlin and Michaelsson 1969; Glenn et al 1972). In
addition, in a preliminary study using prostaglandins E., E , and
F_
j, prostaglandin E. produced theoreatest amount of synovial and
cartilage damage (Teitz and Chrisman, unpublished data). 50 mg
of crystalline prostaglandin E.
*
were dissolved in 95 % ethanol and
diluted to a total volume of 50 ml for a concentration of I mg/ml .
Brummer (1971) demonstrated that the potency of prostaglandin E
solutions deteriorated if they were stored in saline , at room tem
perature, and at a pH less than 5 or greater than 7. Therefore,
this solution (pH 6.0) was separated into 2 cc aliquots and kept at
4 C. Immediately prior to use, the necessary number of aliquots
was diluted with 2 cc sterile saline each to a concentration of
500/fg/ml.
A solution of saline and 95% ethanol in the proportion 1:1 ,
also made up immediately prior to use, was used as a control.
Chloroquine for intramuscular injection was in the form of
Aralen Diphosphate
**
containing 30 mg chloroquine base per
ml of solution.
Sodium salicylate was dissolved in solutions of dextrose and
tap water to concentrations of 5 mg/cc (2 gm NaSal, 5 gm dextrose,
400 cc water) and 7.5 mg/cc ( 3 gm NaSal, 5 gm dextrose, 400 cc
water) ( Moskowitz, personal communication).
*
Prostaglandins were a gift from Dr. John Pike of the Upjohn Company
**
Araien was a gift of Sterling-Winthrop Laboratories
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Twel ve adult female
*
New Zealand White rabbits, mean
weight 4 kg, were divided into three groups. Group 1 received
sodium salicylate solution, p.o. at a concentration of 5.0 mg/cc
as its sole fluid intake (after Moskowitz). At the time intra-articular
prostaglandin injections were begun, the sodium salicylate was in
creased to a concentration of 7 .5 mg/cc and was kept at that
concentration for the remainder of the experiment. The animals in
Group II each received Aralen, 1.3 cc, intramuscularly (or
approximately 9.75 mg/kg) beginning on the day of the first
prostaglandin injection and again, every other day throughout the
study.
Group III received no medication.
The fluid intake for groups II and III was plain tap water
and all animals received Purina Rabbit Chow ad lib. Animals
in groups I and II were v/eighed every other day, whereas those
in group III were weighed every fourth day.
Each rabbit, in turn, was anesthetized with intravenous
pentobarbital **. Its knees were then shaved and cleaned with







In each animal one knee was injected with prostaglandin
solution ( 500/tg PGE ) and the contralateral with control
solution. These intra-articular injections were repeated with
anesthesia at four-day intervals for a total of 20 days ( 5
injections). At the end of this time period the animals were
sacrificed with an overdose of pentobarbital and their knee
joints opened. Samples of joint fluid were obtained on sterile
swabs and culture for bacteria. Specimens of synovium, bone,
and cartilage were taken from the articular surface of the distal
femur and fixed in 12 % formalin. After de-calcification in
formic acid, these specimens were cut for microscopic examination
and stained with hematoxylin and eosin and safranin-o. Sections




The weights of all the animals remained essentially stable
throughout the experiment. Salicylate intake varied from 500
mg/kg/day the first week to approximately 300 mg/kg/day
for the remainder of the experiment producing estimated serum
levels of 85 mg % to 51 mg % (after Moskowitz).
At the time of sacrifice, synovium and articular surfaces
appeared grossly normal bilaterally in all animals. Cultures of
joint fluid taken at that time were uniformly sterile.
Under microscopic examination T the synovial membrane was
scored on the basis of the following criteria:
1) greater than three layers of cells lining the edge of the
membrane
2) a great increase in the amount of fibrous tissue present
or minimal increase in fibrosis but with lymphocytes +
giant cells present
3) loss of fatty tissue layer.
For each of the above noted, the specimen received a +, when
none was present, it was scored 0 (TABLE I ).
Although there was some change in the synovial membrane of
the control-injected side in 9 of 12 rabbits ( FIGURE la), 75%
had even more reaction on the prostaglandin-injected side (FIGURE
lb) with 25 % remaining the same. In no case was the prostaglandin-
injected side better than the control side. Synovial membrane from
the chloroquine-treated group was not significantly different from
either that of the salicylate-treated oroup or the non-medicated
group.
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Cartilage was evaluated primarily on the basis of its staining
characteristics and scored as abnormal if there was loss of safranin
stain in the columnar and transitional layers as this presumably
represented a loss of mucopolysaccharide (Dingle 1962; Collins and
McElligott I960).
Cartilage from control knees was normal in all three groups.
(FIGURES 2-4). In the prostaglandin-injected knees, the cartilage
was abnormal in both the group receiving sodium-salicylate
(FIGURE 2) and that receiving no medication (FIGURE 3) but
remained normal in the group receiving chloroquine (FIGURE 4)
(TABLE II).
10
TABLE I: THE EFFECT OF PROSTAGLANDIN E , SODIUM -SALICYLATE
AND CHLOROQUINE ON SYNOVIAL MEMBRANE
THERAPY no medication sodium-sal icy late chloroquine
ethanol
saline
+ + o o + + + +
+ O + +
PGE,
1
++ ++ ++ ++ + +-H ++ + -H- + + ++
EACH + INDICATES THE PRESENCE OF ONE ABNORMAL FINDING AS
DESCRIBED IN THE TEXT
TABLE II: THE EFFECT OF PROSTAGLANDIN E , SODIUM-SALICYLATE
AND CHLOROQUINE ON CARTILAGE
THERAPY no medication sodium-salicylan te chloroquine
ethanol
&
saline N N N N N N N N N N N N
PGE A A A A
:
A A A N N N N N
N=NORMAL
,






RIGHT :ethanol and saline LEFT: prostaglandin E.
FIGURE I: SYNOVIAL MEMBRANE: a) the control shows a slight increase from the normal 2 layers to 3 layers
of lining cells, but is otherwise within normal limits.
b) PGE injections have produced a disorganization of and an increase in
the number of layers of lining cells, an increased amount of fibrous tissue, and a loss of the fatty
layer normally seen. Magnification
175x
i '$£?:
RIGHl : ethanol and saline LEFT: prostaglandin E
FIGURE PARTICULAR CARTILAGE FROM RABBITS TREATED WITH SODIUM-SALICYLATE:
Cartilage from the prostaglandin-injected knee (b) shows bss of stain when compared
to cartilage from the control knee (a). Magnification I75x
RIGHT: ethanol and saline
FIGURE
LEFT: prostaglandin E
ARTICULAR CARTILAGE FROM RABBITS RECEIVING NO MEDICATION:
Cartilage from the prostaglandin-injected knee (b) shows loss of stain when
compared to cartilage from the control knee (a). Magnification I75x
"
*
-*y.-; <$« a , v ill- •
■'
r
RIGHT: ethanol and saline LEFT: prostaglandin
FIGURE IV: ARTICULAR CARTILAGE FROM RABBITS TREATED WITH CHLOROQUINE:
No change in staining characteristics is seen between the control knee (a) and the
prostaglandin-injected knee (b). Magnification I75x above and 350 x below
DISCUSSION
The conclusions drawn from the experimental results given
above included the following: 1) the synovial membrane was
mildly damaged in the control knees (those injected with ethanol
and saline) either by the mechanics of injection, and/or the
control solution injected. Hence, no valid conclusion could be
drawn as to the effects of prostaglandin E on the synovial mem
brane or modification thereof by the drugs administered. 2) Unlike
the synovial membrane, the articular cartilage v/as not damaged
by the experimental procedure, per se, but was found to undergo
degeneration specifically in the presence of prostaglandin E .
3) This prostaglandin-induced degeneration could be prevented
by the administration of chloroquine but not of sodium-salicylate.
There are a number of questions which arose with respect to
these conclusions. First, what caused the articular cartilage to
dgenerate in the presence of prostaglandin E ? As noted above,
prostaglandin E was shown to have the ability to induce leukocyte
migration (Kaley and Weiner 1971 b) and once polymorphonuclear
leukocytes were present, they might be further stimulated by
prostaglandin E. to release lytic enzymes from their lysosomes.
Indeed Fell and Dingle (1963) suggested that cartilage degradation
could be due to alterations in the composition or stability of the
cells and their organelles, including lysosomes. This suggestion
was extended to the molecular level by Butcher 'and Baird (1969).
Upon find'ng prostaglandin E capable of reducing the level of
cyclic AMP in cells of the fat pad of the rat epididymis, they pro
posed that prostaglandin E could cause perturbation of the cell
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membrane to which adenyl cyclase is bound, thereby decreasing
the production of cyclic AMP and increasing the discharge of
lysosomal hydrolases. Although other authors found prostaglandin
E to stimulate adenyl cyclase, hence increasing the level of
cyclic AMP in platelets (Marquis et al 1969; Roblson et a] 1969),
leukocytes (Bourne and Melmon 1971), liver (Scott 1970), and fibro
blasts (Peery et al 1971; Johnson and Pastan 1971); Al Tai and Graham
(1972) have since provided evidence to support the position of Butcher
and Baird (1969) that prostaglandin E can cause a decrease in the
activity of adenyl cylclase and hence a decrease in the levels of
cyclic AMP. Furthermore, this view supports the finding noted
above, that although prostaglandin E is leukotactic, cyclic AMP
is not (Kaley and Weiner 1971 b).
It can also be implied that cathepsins may be Involved in
the cartilage degradation seen. These acid proteases are normajly
found in cartilage and in increased amounts in areas of degeneration
Chrisman et al 1967). They are known to be capable of degrading
the extracellular matrix of articular cartilage (h\'\ 1964) and may have
a lysosomal origin in the chondrocyte (Chrisman 1969).
The "inal element which all of the above suggested mechanisms
have In common is the lysosome and its release of lytic enzymes.
Dingle (1962) proposed that destruction of articular cartilage in
arthritic diseases could be related to the activation of lysosomal
enzymes. Although Zurier and Weissmann 0971) found prostaglandin
E to inhibit the release of lysosomal hydrolases in polymorphonuclear
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leukocytes, the effects of prostaglandin E on cyclic AMP, as shown
above, are sufficiently controversial that It is not unreasonable to
expect that there may also be a different effect of prostaglandin
E on Ihe lysosomes found in the synovial membrane or in the chondro
cytes themselves.
The second question which arose was, why did the salicylate
not prevent the articular cartilage from degenerating in our system?
If its mechanism of action were as suggested by Anderson (1968) to
inhibit the actions of cathepsins, it would be expected to be pro
tective if they were reponsible for the damage. If it were stabilizing
lysosomes as proposed by Miller and Smith (1966) it should be protective.
One might argue that the salicylate was not effective because sodium-
salicylate, which was used here, was less potent than acetyl-salicylate
In inhibiting prostaglandin synihesis in many systems (Flower et al 1972).
However, the point to be made is that in our type of experimental
arrangement, there is no need for biosynthesis of prostaglandin to
occur. It is introduced already synthesized into the joint.
In othe"Y experiments in which the prostaglandin was placed in
the system instead of relying on its synthesis, even acetyl-salicylate
did not prevent its effects. This was found in vivo when prostaglandins
were injected intra-dermally (Michaelsson 1970), subcutaneously
(Ferreira 1972), Intra-peritoneally (Collier 1972), and intra-articularly
(Rosenthale et a I 1972) and in vitro where once the prostaglandin
synthetic mechanism had begun, it could not be stopped by acetyl-
salicylate (Smith and Lands 1971). Our finding, then, that salicylate
did not protect the articular cartilage from the effects of prostaglandin
E| lends further support to Vane's hypothesis for the mechanism of action
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of aspirin (Vane 1971). Indeed, he intimates that these findings should
be expected since aspirin does not antagonize the effects of existing
prostaglandin but only blocks its production by the tissues
"
(Vane 1972).
Finally, one must ask, why was chloroouine protective against the
effects of prostaglandin E ? Like aspirin, chloroquine can suppress
cathepsin activity as shown in beef nasal cartilage slices (Cowey and
Whitehouse 1966), monkey articular cartilage (Lack and Ali 1967),
and rabbit articular carti lage (Volastro et al 1973). That this suppression
was specific for cathepsin was confirmed by Whitehouse and Cowey (1966)
and Ali et al (1967). However if the suppression of catheptic activity
were chloroquine's mechanism of protective action here, aspirin would
be expected to work also, and as demonstrated, it did not.
Could chloroquine then be acting through its ability to stabilize
lyssomes (Weissmann 1964)? It has been shown in vitro to protect
rabbit liver lysosomes against disruption by lysolecithin, progesterone,
vitamin A, streptolysins and ultraviolet irradiation (Weissmann 1965).
Chloroquine has also suppressed in vitro lymphocyte-C responses which
de"~pend on release of lysosomal enzymes to initiate derepression
(Hurvitz and Hirschhorn 1965). If one believes the hypothesis of Miller
and Smith (1966) that aspirin, too can stabilize lysosomes, then again,
one would not expect the different effects of salicylate and chloroquine
seen.
,
Wherein lies the answer? Miller and Smith (1966) presented
evidence for salicylate's ability to stabilize lysosomes, but they
were unable to duplicate their findings in vivo as the doses of
salicylate required were lethal. On the other hand, Allison and Young
(1964) found chloroquine to be taken up and selectively concentrated
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by lysosomes in lymphocyte cell culture ,and Zwaifler (1964) was also
able to show this in vivo . He found that when chloroquine was placed in
the drinking water of rats and they were sacrificed two to four weeks
later, the largest amount of chloroquine found in any single region was
found in the lysosomal fraction of their homogenized liver cells.
In yet another system (Mallucci 1966), chloroquine was shown to
jnhibit virus reproduction by stabilizing the cell membrane and pre
venting the virus from disrupting lysosomes whose enzymes are necessary
for uncoating the virus so it can induce its reproduction. It would seem,
then, thqt if prostaglandin E Is causing a perturbation of the cell membrane
(Butcher and Balrd 1969) , chloroquine is successfully able to prevent
this whereas salicylate is not. Salicylate can not compete with prostaglandin
on this level but can merely prevent its synthesis, an action which has
been bypassed in our experiment. If salicylate were protective through
some mechanism other than inhibition of prostaglandin synthesis, one
would expect it to prevent the cartilage degradation seen in our system.
Hence, in answer to the question posed earlier, "is the protective
effect of salicylate on cartilage mediated by inhibition of prostaglandin
synthesis and/or release", the evidence presented here supports the theory
that it is. Further experimentation would be necessary for confirmation.
In summdj-y, we have shown that prostaglandin E , when injected
into the rabbit knee produces synovitis and cartilage matrix degradation.
The finding that salicylate cannot prevent this degeneration whereas
chlorocjuine can, is most likely due to their different mechanisms of
afction in this system. Whereas chloroquine's ability to stabilize membranes
is protective in this experiment, salicylate's ability to prevent the bio
synthesis of prostaglandins is bypassed and therefore is not.
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